Technical Analysis for SNY - Sanofi

Grade Last Price % Change Price Change
grade A 44.3 1.61% 0.70
SNY closed up 1.61 percent on Tuesday, September 17, 2019, on 1.37 times normal volume.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical SNY trend table...

Date Alert Name Type % Chg
Cup with Handle Other 0.00%
20 DMA Support Bullish 1.61%
Cup with Handle Other 1.61%
Spinning Top Other 1.61%
Inside Day Range Contraction 1.61%
MACD Bearish Signal Line Cross Bearish 1.35%
20 DMA Support Bullish 1.35%
Cup with Handle Other 1.35%
Outside Day Range Expansion 1.35%
Cup with Handle Other 1.14%

Older signals for SNY ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Sanofi researches, develops, manufactures, and markets healthcare products worldwide. The company operates through Pharmaceuticals, Human Vaccines, and Animal Health segments. Its principal products include Lantus and Apidra analogs of human insulin; Insuman, a range of human insulin solutions and suspensions; Amaryl, an oral once-daily sulfonylurea; BGStar and iBGStar blood glucose meters; enzyme replacement therapies, such as Cerezyme for Gaucher disease, Fabrazyme for Fabry, and Myozyme/Lumizyme for Pompe disease; Aubagio, an oral immunomodulator for multiple sclerosis; Taxotere, a taxane derivative for various cancer types; Eloxatine for colorectal cancer; and Jevtana for prostate cancer. The company's products also consist of thrombosis medicines, such as Plavix anti-platelet agent for atherothrombotic conditions and Lovenox to prevent and treat deep vein thrombosis; and cardiovascular medicines include Multaq anti-arrhythmic agent and Aprovel/CoAprovel for hypertension treatments. It also offers Renagel/Renvela oral phosphate binders used in patients with chronic kidney disease on dialysis to treat high phosphorus levels; Synvisc and Synvisc-One viscosupplements to treat pain associated with osteoarthritis of certain joints; and pediatric and influenza, adult and adolescent booster, meningitis and pneumonia, and travel and endemics vaccines. In addition, the company provides pharmaceuticals and vaccines used by veterinarians, farmers, and pet owners; consumer health care products to treat fever, pain, and digestive health areas; and generic medicines. Sanofi distributes its products through its sales force, as well as through physicians, pharmacies, hospitals, distributors, veterinaries, chemists, and wholesalers. It has alliance arrangements with Bristol-Myers Squibb, Regeneron, and Warner Chilcott. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1970 and is headquartered in Paris, France.
Cancer Healthcare Life Sciences Pharmaceutical Industry Pain Pharmaceuticals Prostate Cancer Health Sciences Multiple Sclerosis Dialysis Influenza Osteoarthritis Chronic Kidney Disease Hypertension Colorectal Cancer Healthcare Products Insulin Cac 40 Hepatotoxins Bristol Myers Squibb Sanofi Fever Pneumonia Pompe Disease Thrombosis Consumer Health Care Products Deep Vein Thrombosis Gaucher Disease Enzyme Replacement Therapies Regeneron
Is SNY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 45.62
52 Week Low 40.0
Average Volume 1,338,132
200-Day Moving Average 42.8016
50-Day Moving Average 42.563
20-Day Moving Average 43.531
10-Day Moving Average 44.068
Average True Range 0.6735
ADX 14.17
+DI 27.4508
-DI 25.3438
Chandelier Exit (Long, 3 ATRs ) 43.0295
Chandelier Exit (Short, 3 ATRs ) 43.8305
Upper Bollinger Band 45.0194
Lower Bollinger Band 42.0426
Percent B (%b) 0.76
BandWidth 6.838345
MACD Line 0.4298
MACD Signal Line 0.4467
MACD Histogram -0.0169
Fundamentals Value
Market Cap 111.26 Billion
Num Shares 2.51 Billion
EPS 4.31
Price-to-Earnings (P/E) Ratio 10.28
Price-to-Sales 2.74
Price-to-Book 1.72
PEG Ratio 1.86
Dividend 1.64
Dividend Yield 3.70%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 45.13
Resistance 3 (R3) 45.05 44.69 44.99
Resistance 2 (R2) 44.69 44.48 44.73 44.95
Resistance 1 (R1) 44.49 44.35 44.59 44.58 44.90
Pivot Point 44.14 44.14 44.18 44.18 44.14
Support 1 (S1) 43.94 43.92 44.04 44.02 43.70
Support 2 (S2) 43.58 43.79 43.62 43.65
Support 3 (S3) 43.39 43.58 43.61
Support 4 (S4) 43.47